Teshima, Takanori <br/><br/>
Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.  [electronic resource] 

 -  International journal of hematology  Sep 2009 
 - 253-260 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-3774 
<br/><br/><label>Standard No.: </label>10.1007/s12185-009-0370-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Adult<br/>Antibodies--blood<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Chronic Disease<br/>Female<br/>Graft vs Host Disease--drug therapy<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Rituximab<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult